Articles dans des revues avec comité de lecture (364)

  1. 34. Compte, N., Dumont, L., Bron, D., De Breucker, S., Praet, J. P., Bautmans, I., & Pepersack, T. (2018). White blood cell counts in a geriatric hospitalized population: A poor diagnostic marker of infection. Experimental gerontology, 114, 87-92. doi:10.1016/j.exger.2018.11.002
  2. 35. Najar, M., Krayem, M., Merimi, M., Burny, A., Meuleman, N., Bron, D., Raicevic, G., & Lagneaux, L. (2018). Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts. Inflammation research. doi:10.1007/s00011-018-1131-1
  3. 36. Najar, M., Fayyad Kazan, M., Meuleman, N., Bron, D., Fayyad Kazan, H., & Lagneaux, L. (2018). Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation. Journal of Cell Communication and Signaling. doi:10.1007/s12079-018-0448-4
  4. 37. Najar, M., Fayyad Kazan, M., Meuleman, N., Bron, D., Fayyad Kazan, H., & Lagneaux, L. (2018). Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture. Molecular and cellular biochemistry, 447(1-2), 111-124. doi:10.1007/s11010-018-3297-9
  5. 38. Najar, M., Krayem, M., Meuleman, N., Bron, D., Busser, H., & Lagneaux, L. (2017). Immunohematology Mesenchymal Stromal Cell-based Therapy: From Research to Clinic. Applied immunohistochemistry & molecular morphology : AIMM. doi:10.1097/PAI.0000000000000629
  6. 39. Najar, M., Fayyad Kazan, M., Meuleman, N., Bron, D., Fayyad Kazan, H., & Lagneaux, L. (2017). Immunomodulatory effects of foreskin mesenchymal stromal cells (FSK-MSCs) on natural killer (NK) cells. Journal of cellular physiology. doi:10.1002/jcp.26305
  7. 40. Libert, Y., Borghgraef, C., Beguin, Y., Delvaux, N., Devos, M., Doyen, C., Dubruille, S., Etienne, A.-M., Liénard, A., Merckaert, I., Reynaert, C., Slachmuylder, J.-L., Straetmans, N., Van Den Neste, E., Bron, D., & Razavi, D. (2017). Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: A longitudinal cohort study. Psycho-oncology, 26(12), 2086-2093. doi:10.1002/pon.4424
  8. 41. Aftimos, P., Van Rompaey, L., Michotte, J.-M., Silence, K., Hultberg, A., Gandini, D., De Haard, H., Ribrag, V., Peeters, M., Thibault, A., Leupin, N., Rolfo, C., Awada, A., Rottey, S., Offner, F., Bron, D., Maerevoet, M., Soria, J.-C., Moshir, M., & Dreier, T. (2017). Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies. Clinical cancer research, 23(21), 6411-6420. doi:10.1158/1078-0432.CCR-17-0613
  9. 42. Fayyad Kazan, H., Fayyad Kazan, M., Merimi, M., Meuleman, N., Bron, D., Lagneaux, L., & Najar, M. (2017). The Micronome of Mesenchymal Stromal Cells is partially responsive to Inflammation. Cell biology international. doi:10.1002/cbin.10897
  10. 43. Bron, D., & Soubeyran, P. (2017). Rational therapeutic choice for older patients with lymphoma. Current opinion in oncology, 29(5), 322-327. doi:10.1097/CCO.0000000000000394
  11. 44. Chaput, F., Amer, R., Baglivo, E., Touitou, V., Kozyreff, A., Bron, D., Bodaghi, B., LeHoang, P., Bergstrom, C. C., Grossniklaus, H. H., Chan, C.-C., Pe’er, J., & Caspers, L. (2017). Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome. Ocular immunology and inflammation, 25(5), 639-648. doi:10.3109/09273948.2016.1139733
  12. 45. Dosin, G., Aoun, F., El Rassy, E., Assi, T., Lewalle, P., Blanc, J., Van Velthoven, R., & Bron, D. (2017). Viral-induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant. Clinical Lymphoma, Myeloma and Leukemia, 17(7), 438-442. doi:10.1016/j.clml.2017.05.013

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37
    38 Suivant >>